{"Symbol": "ANIP", "AssetType": "Common Stock", "Name": "ANI Pharmaceuticals Inc", "Description": "ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets brand-name and generic prescription pharmaceuticals in the United States and Canada. The company is headquartered in Baudette, Minnesota.", "CIK": "1023024", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "DRUG MANUFACTURERS - SPECIALTY & GENERIC", "Address": "210 MAIN STREET WEST, BAUDETTE, MN, UNITED STATES, 56623", "OfficialSite": "https://www.anipharmaceuticals.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-09-30", "MarketCapitalization": "1737364000", "EBITDA": "142412000", "PERatio": "48.35", "PEGRatio": "1.06", "BookValue": "24.19", "DividendPerShare": "None", "DividendYield": "None", "EPS": "1.6", "RevenuePerShareTTM": "41.88", "ProfitMargin": "0.0491", "OperatingMarginTTM": "0.102", "ReturnOnAssetsTTM": "0.0237", "ReturnOnEquityTTM": "0.0866", "RevenueTTM": "826880000", "GrossProfitTTM": "502335000", "DilutedEPSTTM": "1.6", "QuarterlyEarningsGrowthYOY": "-0.169", "QuarterlyRevenueGrowthYOY": "0.536", "AnalystTargetPrice": "110.5", "AnalystRatingStrongBuy": "3", "AnalystRatingBuy": "4", "AnalystRatingHold": "1", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "0", "TrailingPE": "48.35", "ForwardPE": "9.08", "PriceToSalesRatioTTM": "2.101", "PriceToBookRatio": "3.437", "EVToRevenue": "2.524", "EVToEBITDA": "12.76", "Beta": "0.501", "52WeekHigh": "99.5", "52WeekLow": "54.1", "50DayMovingAverage": "81.28", "200DayMovingAverage": "79.32", "SharesOutstanding": "22458200", "SharesFloat": "18895900", "PercentInsiders": "9.994", "PercentInstitutions": "97.757", "DividendDate": "None", "ExDividendDate": "None"}